Skip to main content

Anesthetics Market Size Worth USD 9.55 Billion in 2032 | Emergen Research

Rising demand for minimally invasive surgery is one of the major factors driving anesthetics market revenue growth

Vancouver, Dec. 20, 2023 (GLOBE NEWSWIRE) — The global anesthetics market size was USD 6.80 Billion in 2022 and is expected to register a steady revenue CAGR of 3.5% during the forecast period, according to latest analysis by Emergen Research. Rising demand for minimally invasive surgery is the primary factor driving market revenue growth. Anesthetics are medications that are used to block individual from feeling pain during medical procedures. Need for specialized anesthetics tailored to these techniques is rising as patients and healthcare providers increasingly recognize the benefits of minimally invasive procedures such as reduced postoperative pain, shorter recovery times, and smaller incisions.

In addition, rising number of surgical procedures is another key factor driving revenue growth of the market. Healthcare providers are seeking anesthesia solutions that ensure successful surgical outcomes and also prioritize patient well-being throughout the period. Moreover, technological advancements in drug formulations is also expected to drive market revenue growth during the forecast period.

These advancements not only enhance patient experiences by minimizing postoperative discomfort but also provide healthcare professionals with more precise control over anesthesia administration. However, side effects and safety concerns associated with certain anesthesia formulations, such as nausea, vomiting, allergic reactions, and respiratory problems, is a key factor, which could restrain market revenue growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2608

Scope of Research

Report DetailsOutcome
Market Size in 2022USD 6.80 Billion
CAGR (2023–2032)3.5%
Revenue Forecast To 2032USD  9.55  Billion
Base Year For Estimation2022
Historical Data2019–2021
Forecast Period2023–2032
Quantitative UnitsRevenue in USD Billion and CAGR in % from 2023 to 2032
Report CoverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments CoveredDrug type, modality, mode of administration, application, end-use and region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country ScopeU.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa
Key Companies ProfiledPfizer Inc., AbbVie Inc., Viatris Inc., Fresenius Kabi AG, Baxter International Inc., EMS Pharma, AstraZeneca, Hikma Pharmaceuticals PLC, EUROFARMA, ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A, Cristália, DFL, Avet Pharmaceuticals Inc., Wockhardt, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Maruishi Pharmaceutical. Co., Ltd., Piramal Enterprises Ltd., F. Hoffmann-La Roche Ltd., B. Braun SE, and Mallinckrodt. 
Customization Scope10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2608

MAJOR COMPANIES and Market Share Analysis

The global anesthetics market is fragmented with large and medium-sized market players accounting for the majority of revenue. Major players are deploying various strategies, entering into mergers and acquisitions, strategic agreements and contracts, developing, testing, and introducing more effective anesthetics products in the market. Some major players included in the global anesthetics market report are:

  • Pfizer Inc.
  • AbbVie Inc.
  • Viatris Inc.
  • Fresenius Kabi AG
  • Baxter International Inc.
  • EMS Pharma
  • AstraZeneca
  • Hikma Pharmaceuticals PLC.
  • EUROFARMA
  • ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A.
  • Cristália
  • DFL
  • Avet Pharmaceuticals Inc.
  • Wockhardt
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Maruishi Pharmaceutical. Co., Ltd.
  • Piramal Enterprises Ltd.
  • F. Hoffmann-La Roche Ltd.
  • B. Braun SE
  • Mallinckrodt

Strategic Development

  • On 10 January 2023, Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provides painless and precise injections, announced a distribution agreement granting TEKMIKA Health Technologies exclusive distribution rights to market Milestone’s STA Single Tooth Anesthesia System (STA) in Brazil. Leading Brazilian distributor TEKMIKA Health Technologies specializes in importation, advertising, marketing, and distribution of cutting-edge medical gadgets and equipment. Using a fully digital, holistic environment to help the sales staff and clients, SUPREVIDA handle all digital marketing for the STA and disposables.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2608

Some Key Highlights from the Report

  • The inhalation anesthetics segment accounted for largest revenue share in the global anesthetics market in 2022. This is due to rising demand for inhalation anesthetics, such as nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane, which are used to induce and maintain general anesthesia, in the operating room. Inhaled anesthetics are frequently used in conjunction with intravenous anesthetic drugs and have Food and Drug Administration (FDA) approval for use in the operating room as a general anesthetic and sedative agent.
  • Inhalation aesthetics ensures that patients remain pain-free throughout surgical procedures, a critical consideration for major surgeries and interventions. The controllable nature of inhalation anesthetics enables healthcare providers to adjust the depth of anesthesia in accordance with individual needs of the patient and specific requirements of surgical procedure. In addition, increasing availability of various inhalation anesthetics provides healthcare professionals with a range of options, allowing to tailor anesthesia to meet the specific needs of each patient and procedural context.
  • The dental clinics segment is expected to register steadily fast revenue growth rate in the global anesthetics market during the forecast period. This is due to increasing need for anesthetics in dental clinics signifies an encompassing approach to oral healthcare, prioritizing patient comfort and successful execution of a diverse range of dental procedures. Procedures, such as oral surgeries, implant placements, and periodontal interventions, demand a high level of precision, and anesthetics are instrumental in creating optimal conditions for their successful completion

Segments Covered in Report

Emergen Research has segmented the global anesthetics market on the basis of drug type, modality, mode of administration, application, end-use, and region:

  • Drug Type Outlook (Revenue, USD Billion; 2019–2032)
    • General Anesthetics
      • Isoflurane
      • Sevoflurane
      • Thiopental
      • Etomidate
      • Rocuronium
      • Ataracurium
      • Fentanyl
      • Others
    • Local Anesthetics
      • Lidocaine
      • Bupivacaine
      • Ropivacaine
      • Others
    • Others
  • Mode of Administration Outlook (Revenue, USD Billion; 2019–2032)
    • Inhalation Anesthetics
    • Intravenous (IV) Anesthetics
    • Topical and Local Anesthetics
    • Neuromuscular Blockers
    • Others
  • Application Outlook (Revenue, USD Billion; 2019–2032)
    • General Surgery
    • Plastic Surgery
    • Cosmetic Surgery
    • Dental Surgery
    • Others
  • End-use Outlook (Revenue, USD Billion; 2019–2032)
    • Hospitals and Clinics
    • Dental Clinics
    • Ambulatory Surgical Centers (ASCs)
    • Others
  • Regional Outlook (Revenue, USD Billion; 2019-2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of Middle East & Africa

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/anesthetics-market

Curated Reports You Shouldn’t Miss: Dive In Now!

Sepsis Diagnostics Market, By Technology (Immunoassays, Molecular Diagnostics), By Product (Blood Culture Media, Instruments), By Method, By Pathogen Type, By Test Type, By End-use, and By Region Forecast to 2030

Managed Security Services Market, By Service Type By Type (Fully Managed Security Services and Co-managed Security Services), By Security Type, By Organization Size, By Vertical, and By Region Forecast to 2032

Stereotactic Surgery Devices Market, By Product Type [Gamma Knife, Linear Accelerator (LINAC), Proton Beam Radiation Therapy, and Cyber Knife], By Application, By End-use (Hospitals, and Laboratories), and By Region Forecast to 2032

Intraoperative Imaging Market, By Product [Mobile C arm, Computed Tomography (CT) Scan)], By Application, By Component, By End-use, and By Region Forecast to 2032

Dental Implants and Prosthesis Market, By Design (Tapered Dental Implants and Others), By Material, By Type, By Price, By Application, and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-anesthetics-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.